{"id":1188,"date":"2019-10-21T00:17:26","date_gmt":"2019-10-21T00:17:26","guid":{"rendered":"http:\/\/milu01.eastasia.cloudapp.azure.com\/?page_id=1188"},"modified":"2021-03-30T15:41:32","modified_gmt":"2021-03-30T07:41:32","slug":"our-team","status":"publish","type":"page","link":"https:\/\/www.milulabs.com\/zh\/our-team\/","title":{"rendered":"\u56e2\u961f\u4ecb\u7ecd"},"content":{"rendered":"
<\/div><\/div>
<\/div><\/div>
\n <\/path> <\/path> <\/path>\n <\/svg><\/div>
\n\t
\n\t\t
<\/div><\/div>\n\t\t\t
\n\t\t\t\t
<\/div> <\/div>
\n\t
\n\t\t
<\/div><\/div>\n\t\t
\n\t\t\t\r\n
\r\n\t
\r\n\t\t
\u56fd\u9645\u9886\u5bfc\u529b<\/h5>\n

\u6211\u4eec\u7684\u56e2\u961f\u7279\u522b\u9002\u5408\u5728\u5168\u7403\u5f00\u53d1\u548c\u5546\u4e1a\u5316\u7a81\u7834\u6027\u7684\u533b\u7597\u6280\u672f\u3002<\/h2>\n\t<\/div>\r\n<\/div>\r\n\r\n\r\n\r\n\n\t\t<\/div> \n\t<\/div>\n\t<\/div> \n<\/div><\/div>\n\t\t\t<\/div> \n\t\t<\/div>\n\t<\/div> \n\n\t
\n\t\t
<\/div><\/div>\n\t\t\t
\n\t\t\t\t\n\t\t\t<\/div> \n\t\t<\/div>\n\t<\/div> \n<\/div><\/div>\n\t\t
<\/div><\/div>
<\/div><\/div>
\n\t
\n\t\t
<\/div><\/div>\n\t\t\t
\n\t\t\t\t\r\n
\r\n\t
\r\n\t\t

\u7ba1\u7406\u56e2\u961f<\/span><\/h2>\n\t<\/div>\r\n<\/div>\r\n\r\n\r\n\r\n
<\/div><\/div>
<\/div> <\/div>
\n\t
\n\t\t
<\/div><\/div>\n\t\t
\n\t\t\t
\"Daniel<\/div><\/div>
<\/div>
Co-Founder & Executive Chairman<\/h5>

Daniel Chai \u8521\u5cb1\u9570\uff0c\u533b\u5b66\u535a\u58eb<\/h3>

<\/p>

<\/polyline> <\/svg><\/span> <\/a><\/span><\/div><\/div>
<\/div>
Dr. Daniel Chai is Co-Founder and Executive Chairman of Milu Labs. Prior to founding the company, Dr. Chai was a healthcare investor with close to two decades of investment experience.<\/p>\n

\u4ed6\u76ee\u524d\u662f\u706f\u5854\u6295\u8d44\u7684\u7ba1\u7406\u5408\u4f19\u4eba\u3002\u706f\u5854\u6295\u8d44\u662f\u4e00\u5bb6\u5728\u533b\u7597\u4fdd\u5065\u516c\u53f8\u8fdb\u884c\u5b75\u5316\u548c\u6295\u8d44\u7684\u5168\u7403\u6295\u8d44\u516c\u53f8\u3002\u4ed6\u66fe\u5728\u51e0\u5bb6\u9886\u5148\u7684\u516c\u53f8\u62c5\u4efb\u6295\u8d44\u7ec4\u5408\u7ecf\u7406\uff0c\u9886\u5bfc\u7740\u533b\u7597\u4fdd\u5065\u6295\u8d44\u56e2\u961f\uff0c\u5305\u62ec\u57ce\u5821\u6295\u8d44\u96c6\u56e2\u3001\u745e\u94f6\u96c6\u56e2\uff08\u81ea\u8425\u4ea4\u6613\u96c6\u56e2\uff09\u548c\u7ebd\u4f2f\u683c\u4f2f\u66fc\u3002\u4ed6\u5728Nexgen Spine\u7684\u8463\u4e8b\u4f1a\u4efb\u804c\uff0c\u65e2\u6709\u65e9\u671f\u6295\u8d44\u7ecf\u9a8c\uff0c\u53c8\u6709\u6218\u7565\u7ecf\u9a8c\uff0c\u8be5\u8463\u4e8b\u4f1a\u88abStryker Corporation\u6536\u8d2d\u3002<\/p>\n

\u4ed6\u62e5\u6709\u5bc6\u6b47\u6839\u5927\u5b66\u7684\u5b66\u58eb\u5b66\u4f4d\uff0c\u5e76\u83b7\u5f97\u4e86\u54e5\u4f26\u6bd4\u4e9a\u5927\u5b66\u5185\u5916\u79d1\u533b\u5b66\u9662\u7684\u533b\u5b66\u535a\u58eb\u5b66\u4f4d\u3002

<\/div><\/div> <\/div>\n\t\t<\/div> \n\t<\/div>\n\t<\/div> \n\n\t
\n\t\t
<\/div><\/div>\n\t\t
\n\t\t\t
\"Wilson<\/div><\/div>
<\/div>
President & Chief Executive Officer<\/h5>

\u5f20\u7ef4\u94a7\uff0c\u533b\u5b66\u535a\u58eb<\/h3>

<\/p>

<\/polyline> <\/svg><\/span> <\/a><\/span><\/div><\/div>
<\/div>
Dr. Wilson Zhang is Co-Founder, President and Chief Executive Officer of Milu Labs, he formerly served as the Lead of Strategy and Corporate Development at Zhejiang Dian Diagnostics Co, one of the largest diagnostic labs in China and is publicly traded on the Shenzhen Stock Exchange. He has focused on establishing strategic collaborations with international and national IVD companies.<\/p>\n

\u5f20\u535a\u58eb\u5df2\u6210\u529f\u7ba1\u7406\u4e86\u6574\u4e2a\u8bca\u65ad\u9886\u57df\u7684\u591a\u4e2a\u4e2d\u56fd\u5165\u5883\u9879\u76ee\uff0c\u5305\u62ec\uff1a<\/p>\n

\u2022 \u57fa\u7840\u533b\u5b66\uff08\u4e2a\u6027\u5316\u80bf\u7624\u4f34\u968f\u8bca\u65ad\uff09
\n\u2022 Ariosa Diagnostics\uff08NIPT\uff09
\n\u2022 Otogenetics Corporation\uff08\u65b0\u4e00\u4ee3\u6d4b\u5e8f\uff09
\n\u2022 Biocore Co\uff08\u57fa\u56e0\u68c0\u6d4b\uff09
\n\u2022 Metabolon Inc \uff08\u4ee3\u8c22\u7ec4\u5b66\uff09
\n\u2022 \u7ea6\u7ff0\u970d\u666e\u91d1\u65af\u533b\u9662\uff08\u5927\u5b66\u7684\u5168\u5957\u8bca\u65ad\u9879\u76ee\uff09<\/p>\n

\u4ed6\u8fd8\u662f\u4e0a\u6d77ImmunoTech Bioscience\u516c\u53f8\u7684\u8054\u5408\u521b\u59cb\u4eba\u548c\u524d\u9996\u5e2d\u6280\u672f\u5b98\u3002\u6b64\u524d\uff0c\u5f20\u535a\u58eb\u66fe\u5728\u8fbe\u7279\u8305\u65af\u5b66\u9662\u62c5\u4efb\u5b9e\u9a8c\u5ba4\u7ecf\u7406\u548c\u9ad8\u7ea7\u7814\u7a76\u5458\uff0c\u4e3b\u8981\u7814\u7a76\u514d\u75ab\u5b66\u3002\u4ed6\u62e5\u6709\u4e0a\u6d77\u4ea4\u901a\u5927\u5b66\u533b\u5b66\u9662\u7684\u533b\u5b66\u535a\u58eb\u5b66\u4f4d\uff0c\u91cc\u7ef4\u5c14\u5927\u5b66\u7406\u5b66\u7855\u58eb\u5b66\u4f4d\uff0c\u5e76\u8fdb\u4fee\u4e86\u8fbe\u7279\u8305\u65af\u5854\u514b\u5546\u5b66\u9662\u4f01\u4e1a\u5bb6\u8bfe\u7a0b\u3002

<\/div><\/div> <\/div>\n\t\t<\/div> \n\t<\/div>\n\t<\/div> \n\n\t
\n\t\t
<\/div><\/div>\n\t\t
\n\t\t\t
\"Matthew<\/div><\/div>
<\/div>
Co-Founder & Chief Financial Officer & Chief Strategy Officer<\/h5>

Matthew G. Badalucco \u9a6c\u4fee\u667a<\/h3>

<\/p>

<\/polyline> <\/svg><\/span> <\/a><\/span><\/div><\/div>
<\/div>
Matthew G. Badalucco is Co-Founder, Chief Financial Officer and Chief Strategy Officer of Milu Labs. Mr. Badalucco has over a decade of investment experience across developed and emerging markets. He most recently was the Director of Investment Strategy at Catcha Group, one of the largest venture builders in Asia. There, he advised the CEO and charted the investment approach for the firm\u2019s activities across the region by evaluating transactions across Malaysia, Indonesia, Thailand, Vietnam, Singapore, and the Philippines. In addition, he analyzed growth equity opportunities across China as Assistant Portfolio Manager at Sandell Asset Management and also worked in Dr. Chai\u2019s team at Citadel Investment Group. He holds an A.B. with Honors from Dartmouth College, an M.B.A. from MIT, and an M.P.A. from Harvard University.
<\/div><\/div> <\/div>\n\t\t<\/div> \n\t<\/div>\n\t<\/div> \n<\/div><\/div>
<\/div> <\/div>
\n\t
\n\t\t
<\/div><\/div>\n\t\t
\n\t\t\t
\"Ludy<\/div><\/div>
<\/div>
\u5546\u52a1\u62d3\u5c55\u603b\u76d1<\/h5>

\u9c8d\u5f15\u5065<\/h3>

<\/p>

<\/polyline> <\/svg><\/span> <\/a><\/span><\/div><\/div>
<\/div>
\u9c8d\u5f15\u5065\u535a\u58eb\u4f5c\u4e3a\u5546\u52a1\u62d3\u5c55\u9ad8\u7ba1\u5df2\u5728\u8be5\u9886\u57df\u5de5\u4f5c\u4e86\u8fd130\u5e74\u3002\u4ed6\u7684\u5e7f\u6cdb\u7ecf\u9a8c\u5305\u62ec\u533b\u7597\u8bd5\u5242\u7684\u5546\u4e1a\u5f00\u53d1\u3001\u6750\u6599\u6d88\u8017\u3001\u5b9e\u9a8c\u5ba4\u8bbe\u5907\u4ee5\u53ca\u8fd0\u8425\u7ba1\u7406\u3002<\/p>\n

\u4ed6\u66fe\u62c5\u4efbWIPAK\u96c6\u56e2\u7684\u4e2d\u56fd\u5168\u8d44\u5b50\u516c\u53f8\u516c\u5171\u536b\u751f\u4ea7\u54c1\u603b\u8d1f\u8d23\u4eba\uff0cWIPAK\u96c6\u56e2\u662f\u4e00\u5bb6\u603b\u90e8\u4f4d\u4e8e\u82ac\u5170\u7684\u5168\u7403\u6027\u7efc\u5408\u4f01\u4e1a\uff0c\u5728\u8be5\u96c6\u56e2\u4e2d\uff0c\u4ed6\u5168\u6743\u8d1f\u8d23\u8be5\u7c7b\u4ea7\u54c1\u7684\u8fdb\u53e3\u8ba1\u5212\u3001\u7269\u6d41\u3001\u8bb8\u53ef\u8bc1\u62a5\u6279\u3001\u5e02\u573a\u3001\u9500\u552e\u7f51\u7edc\u7684\u5efa\u8bbe\u548c\u7ba1\u7406\u3002<\/p>\n

Previously, he was the Area Sales Manager of Shanghai Worldeast Commercial & Industrial Co; there, he fulfilled his role as the Sole Agent of Abbott Murex Diagnostic Products in China. Accordingly, he was responsible for channel management and sales of all Abbott Murex\u2019s diagnostic products, including the automatic immunological analysis systems of DYNEX and Genesis; he was also managing the sales processes of other instruments such as the Fresenius blood transfusion system and the Abbott Determine rapid diagnostic products for CDC and CIQ.<\/p>\n

\u5305\u535a\u58eb\u5728\u4e0a\u6d77\u4ea4\u901a\u5927\u5b66\u533b\u5b66\u9662\u83b7\u5f97\u4e86\u533b\u5b66\u535a\u58eb\u5b66\u4f4d\u3002

<\/div><\/div> <\/div>\n\t\t<\/div> \n\t<\/div>\n\t<\/div> \n\n\t
\n\t\t
<\/div><\/div>\n\t\t
\n\t\t\t
\"Mark<\/div><\/div>
<\/div>
Industry Research Analyst<\/h5>

Haohuan (Mark) Li, M.S.<\/h3>

<\/p>

<\/polyline> <\/svg><\/span> <\/a><\/span><\/div><\/div>
<\/div>
Mark is an investment and finance professional with a wide range of experience in China. He was formerly a Vice President in the Asset Management division at Huarong International Financial Holdings Limited, a Hong Kong-listed licensed company (0993.HK), and a subsidiary of China Huarong Asset Management Co., Ltd. (2799.HK), one of the four asset management companies established by the Ministry of Finance of PRC. He conducted several equity and bond investments. He also coordinated establishment of funds in cooperation with reputative financial institutions.<\/p>\n

Before that, Mark served as Business Development Manager and Investor Relations Manager at Hao Tian Development Group Limited, a Hong Kong-listed company (0474.HK). He focused on growing opportunities in China and contributed to investment, financing and operation in mineral, energy, healthcare and agricultural industries.<\/p>\n

Mark holds a BCom in Finance from the Haskyne School of Business, University of Calgary, an M.S. in International Banking and Finance from Ling Nan University, and an Executive Diploma in Merger and Acquisition from HKU SPACE.

<\/div><\/div> <\/div>\n\t\t<\/div> \n\t<\/div>\n\t<\/div> \n\n\t
\n\t\t
<\/div><\/div>\n\t\t
\n\t\t\t
\"Ziyun<\/div><\/div>
<\/div>
Director of Corporate Affairs<\/h5>

Ziyun Zhang<\/h3>

<\/p>

<\/polyline> <\/svg><\/span> <\/a><\/span><\/div><\/div>
<\/div>
Ms. Ziyun Zhang is our Director of Corporate Affairs. She has extensive experience in managing the operations, strategic partnerships, and public relations of large, multinational companies.<\/p>\n

Before joining Milu Labs, she had spent close to 30 years occupying leadership positions in Mcdonald\u2019s China. Zhang pioneered the establishment of the first Ronald McDonald House in China, leading the Ronald McDonald House Charity project across the country. As a core aspect of this initiative, she coordinated with top-tier children\u2019s hospitals and provided accommodation services for families in need; for example, she led the establishment of the Shanghai Ronald McDonald House and cooperated with the Shanghai Children Medicine Center in 2020. In addition, she directed McDonald\u2019s Public Relations and Corporate Affairs departments in Beijing and China\u2019s northern region from 1996 to 2014.<\/p>\n

Ms. Zhang has a M.S. in Oral Medicine and a B.S. in Stomatology from Capital Medical University.

<\/div><\/div> <\/div>\n\t\t<\/div> \n\t<\/div>\n\t<\/div> \n<\/div><\/div>\n\t\t\t<\/div> \n\t\t<\/div>\n\t<\/div> \n<\/div><\/div>\n\t\t
<\/div><\/div>
<\/div><\/div>
\n\t
\n\t\t
<\/div><\/div>\n\t\t\t
\n\t\t\t\t\r\n
\r\n\t
\r\n\t\t

\u79d1\u5b66\u987e\u95ee\u59d4\u5458\u4f1a<\/h2>\n\t<\/div>\r\n<\/div>\r\n\r\n\r\n\r\n
<\/div><\/div>
<\/div> <\/div>
\n\t
\n\t\t
<\/div><\/div>\n\t\t
\n\t\t\t
\"Thomas<\/div><\/div>
<\/div>
\u79d1\u5b66\u987e\u95ee<\/h5>

Thomas McElrath\uff0c\u533b\u5b66\u535a\u58eb<\/h3>

<\/p>

<\/polyline> <\/svg><\/span> <\/a><\/span><\/div><\/div>
<\/div>
McElrath\u535a\u58eb\u662f\u54c8\u4f5b\u533b\u5b66\u9662\u7684\u6559\u6388\uff0c\u4ed6\u5728\u90a3\u91cc\u6559\u6388\u548c\u7814\u7a76\u4e8620\u591a\u3002\u4ed6\u7684\u7814\u7a76\u91cd\u70b9\u662f\u751f\u7269\u6807\u5fd7\u7269\u6d41\u884c\u75c5\u5b66\uff0c\u7279\u522b\u662f\u65e9\u4ea7\u548c\u5185\u5206\u6ccc\u4e2d\u65ad\u598a\u5a20\u3002\u4ed6\u8fd8\u5728\u5e03\u83b1\u6839\u5987\u5973\u533b\u9662\u6267\u4e1a\uff0c\u4ed6\u7684\u4e34\u5e8a\u91cd\u70b9\u4e5f\u662f\u65e9\u4ea7\u3002\u4ed6\u83b7\u5f97\u4e86\u5bc6\u6b47\u6839\u5927\u5b66\u5b66\u58eb\u5b66\u4f4d;\u5bbe\u5915\u6cd5\u5c3c\u4e9a\u5927\u5b66\u7684\u535a\u58eb\u5b66\u4f4d\uff0c\u54c8\u4f5b\u533b\u5b66\u9662\u7684\u533b\u5b66\u535a\u58eb\u5b66\u4f4d\u3002
<\/div><\/div> <\/div>\n\t\t<\/div> \n\t<\/div>\n\t<\/div> \n\n\t
\n\t\t
<\/div><\/div>\n\t\t
\n\t\t\t
\"Daniel<\/div><\/div>
<\/div>
\u79d1\u5b66\u987e\u95ee<\/h5>

Daniel W. Chan\uff0c\u535a\u58eb, \u7f8e\u56fd\u4e34\u5e8a\u5316\u5b66\u5bb6\u8d44\u683c, \u7f8e\u56fd\u4e34\u5e8a\u751f\u7269\u5316\u5b66\u5b66\u4f1a\u7814\u7a76\u5458<\/h3>

<\/p>

<\/polyline> <\/svg><\/span> <\/a><\/span><\/div><\/div>
<\/div>
Daniel W. Chan\u535a\u58eb\u662f\u7ea6\u7ff0\u970d\u666e\u91d1\u65af\u5927\u5b66\u6559\u6388\u3002\u4ed6\u8fd8\u62c5\u4efb\u7ea6\u7ff0\u970d\u666e\u91d1\u65af\u5927\u5b66\u4e34\u5e8a\u5316\u5b66\u79d1\u4e3b\u4efb\u3001\u75c5\u7406\u5b66\u6838\u5fc3\u5b9e\u9a8c\u5ba4\u526f\u4e3b \u4efb\u3002\u4ed6\u7684\u7814\u7a76\u91cd\u70b9\u662f\u75c5\u7406\u5b66\uff0c\u80bf\u7624\u5b66\uff0c\u653e\u5c04\u5b66\u548c\u6ccc\u5c3f\u5b66\u3002\u4ed6\u64b0\u5199\u4e865\u672c\u4e66\uff0c40\u672c\u4e66\u7ae0\u548c300\u7bc7\u79d1\u5b66\u6587\u7ae0\u3002<\/p>\n

Chan\u535a\u58eb\u66fe\u591a\u6b21\u83b7\u5956\uff0c\u5305\u62ecMortonK.Schwartz\u764c\u75c7\u7814\u7a76\u8bca\u65ad\u5956\uff0cAlbertNichols\u5b9e\u9a8c\u533b\u5b66\u6218\u7565\u521b\u65b0\u5956\uff0c\u4ee5\u53ca Bernard Gerulat\u4e34\u5e8a\u5316\u5b66\u6770\u51fa\u6210\u5c31\u5956\u3002\u4ed6\u83b7\u5f97\u4e86\u4fc4\u52d2\u5188\u5927\u5b66\u7684\u5b66\u58eb\u5b66\u4f4d;\u7ebd\u7ea6\u5dde\u7acb\u5927\u5b66\u5e03\u6cd5\u7f57\u5206\u6821\u7684\u535a\u58eb\u5b66\u4f4d\u3002

<\/div><\/div> <\/div>\n\t\t<\/div> \n\t<\/div>\n\t<\/div> \n\n\t
\n\t\t
<\/div><\/div>\n\t\t
\n\t\t\t
\"Zhen<\/div><\/div>
<\/div>
\u79d1\u5b66\u987e\u95ee<\/h5>

\u5f20\u771f\uff0c\u535a\u58eb<\/h3>

<\/p>

<\/polyline> <\/svg><\/span> <\/a><\/span><\/div><\/div>
<\/div>
\u5f20\u535a\u58eb\u662f\u7ea6\u7ff0\u970d\u666e\u91d1\u65af\u5927\u5b66\u75c5\u7406\u5b66\u548c\u80bf\u7624\u5b66\u526f\u6559\u6388\u3002\u4ed6\u8fd8\u62c5\u4efb\u7ea6\u7ff0\u970d\u666e\u91d1\u65af\u5927\u5b66\u751f\u7269\u6807\u8bb0\u7269\u53d1\u73b0\u548c\u7ffb\u8bd1\u4e2d\u5fc3\u7684\u526f\u4e3b\u4efb\u3002\u5f20\u535a\u58eb\u7684\u4e13\u957f\u5305\u62ec\u764c\u75c7\u3001\u86cb\u767d\u8d28\u7ec4\u5b66\u3001\u751f\u7269\u6807\u5fd7\u7269\u5f00\u53d1\u3001\u751f\u7269\u6807\u5fd7\u7269\u53d1\u73b0\u3001\u6570\u5b66\u7b97\u6cd5\u548c\u751f\u7269\u7edf\u8ba1\u5b66\u3002<\/p>\n

\u4ed6\u4e0eChan\u535a\u58eb\u5408\u4f5c\u5f00\u53d1\u4e86\u9996\u4e2a\u7531FDA\u6279\u51c6\u7528\u4e8e\u4e34\u5e8a\u7684\u86cb\u767d\u8d28\u7ec4\u751f\u7269\u6807\u5fd7\u7269\u7684\u4f53\u5916\u8bca\u65ad\u591a\u5143\u6307\u6570\u6d4b\u5b9a(IVDMIA)\u3002\u4ed6\u8fd8\u53d1\u8868\u4e86130\u591a\u7bc7\u6587\u7ae0\uff0c\u91cd\u70b9\u5173\u6ce8\u751f\u7269\u6807\u5fd7\u7269\u5206\u6790\u548c\u751f\u7269\u4fe1\u606f\u5b66\u3002

<\/div><\/div> <\/div>\n\t\t<\/div> \n\t<\/div>\n\t<\/div> \n\n\t
\n\t\t
<\/div><\/div>\n\t\t
\n\t\t\t
\"Gail<\/div><\/div>
<\/div>
\u79d1\u5b66\u987e\u95ee<\/h5>

Gail S. Page<\/h3>

<\/p>

<\/polyline> <\/svg><\/span> <\/a><\/span><\/div><\/div>
<\/div>
Gail Page\u662f\u533b\u7597\u4fdd\u5065\u548c\u8bca\u65ad\u884c\u4e1a\u7684\u9886\u5bfc\u8005\u3002\u5979\u66fe\u62c5\u4efbVermillion\u516c\u53f8\u7684\u603b\u88c1\u3001\u9996\u5e2d\u6267\u884c\u5b98\u548c\u4e3b\u5e2d\u3002\u8be5\u516c\u53f8\u662f\u4e00\u5bb6\u4e13\u6ce8\u4e8e\u5f00\u53d1\u548c\u5546\u4e1a\u5316\u65b0\u578b\u591a\u539f\u5b50\/MAAA\u8840\u6db2\u68c0\u6d4b\u89e3\u51b3\u65b9\u6848\u7684\u533b\u7597\u5065\u5eb7\u516c\u53f8\u3002\u5728Vermillion, \u5979\u4e0eQuest Diagnostics\u5efa\u7acb\u4e86\u5408\u4f5c\u5173\u7cfb\uff0c\u5e76\u76d1\u7ba1\u4e86\u9996\u6b21FDA\u6279\u51c6\u7684\u3001\u5e2e\u52a9\u8bca\u65ad\u5375\u5de2\u764c\u7684\u8840\u6db2\u68c0\u6d4b\u7684\u5546\u54c1\u4e0a\u5e02\u3002<\/p>\n

\u76ee\u524d\u7684\u8463\u4e8b\u4f1a\u4efb\u547d\u5305\u62ecSword Diagnostics\uff0cInc.\uff0cNxPrenatal\uff0cInc. \u548cChembio (\u7eb3\u65af\u8fbe\u514b\u80a1\u7968\u4ee3\u7801:CEMI)\u3002\u5979\u88ab\u4efb\u547d\u4e3a\u6234\u5c14\u533b\u5b66\u9662Catalyst\/\u5fb7\u514b\u8428\u65af\u5927\u5b66\u8463\u4e8b\u4f1a\u7684\u9996\u5e2d\u5546\u52a1\u987e\u95ee\u3002\u4f5b\u7f57\u91cc\u8fbe\u5927\u5b66\u7406\u5b66\u5b66\u58eb;\u897f\u5317\u5927\u5b66\u51ef\u6d1b\u683c\u7ba1\u7406\u5b66\u9662\u9ad8\u7ba1\u6559\u80b2\u3002

<\/div><\/div> <\/div>\n\t\t<\/div> \n\t<\/div>\n\t<\/div> \n<\/div><\/div>\n\t\t\t<\/div> \n\t\t<\/div>\n\t<\/div> \n<\/div><\/div>","protected":false},"excerpt":{"rendered":"GLOBAL LEADERSHIP Our team is uniquely suited to develop and commercialize breakthrough medical technologies globally Management Team Co-Founder & Executive ChairmanDaniel Chai, MD Dr. Daniel Chai is Co-Founder and Executive...","protected":false},"author":2,"featured_media":0,"parent":0,"menu_order":0,"comment_status":"closed","ping_status":"closed","template":"","meta":[],"_links":{"self":[{"href":"https:\/\/www.milulabs.com\/zh\/wp-json\/wp\/v2\/pages\/1188"}],"collection":[{"href":"https:\/\/www.milulabs.com\/zh\/wp-json\/wp\/v2\/pages"}],"about":[{"href":"https:\/\/www.milulabs.com\/zh\/wp-json\/wp\/v2\/types\/page"}],"author":[{"embeddable":true,"href":"https:\/\/www.milulabs.com\/zh\/wp-json\/wp\/v2\/users\/2"}],"replies":[{"embeddable":true,"href":"https:\/\/www.milulabs.com\/zh\/wp-json\/wp\/v2\/comments?post=1188"}],"version-history":[{"count":27,"href":"https:\/\/www.milulabs.com\/zh\/wp-json\/wp\/v2\/pages\/1188\/revisions"}],"predecessor-version":[{"id":1355,"href":"https:\/\/www.milulabs.com\/zh\/wp-json\/wp\/v2\/pages\/1188\/revisions\/1355"}],"wp:attachment":[{"href":"https:\/\/www.milulabs.com\/zh\/wp-json\/wp\/v2\/media?parent=1188"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}